CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL
This is a phase II clinical study to evaluate the safety and efficacy of CAR-T-19 injection in the treatment of CD19-positive relapsed/refractory B-cell acute lymphoblastic leukemia.
Voluntary participation in clinical trial, The Participants or his legal guardia... [+11]
Isolated extra-medullary disease relapse . [+17]